FindTrial
Sign In

This study observes How the Amount of Isoniazid in Blood affect the Treatment success and side effects in adult Tuberculosis Patients

Assessment of Plasma Isoniazid levels, treatment outcome and incidence of adverse drug reactions in adult TB patients-A prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/083958
Enrollment
62
Registered
2025-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Department of Pharmacology AIIMS Mangalagiri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adult patients of either gender more than 18yrs of age newly diagnosed pulmonary and extrapulmonary tuberculosis. 2. Patients weighing more than 38kgs are included

Exclusion criteria

Exclusion criteria: HIV positive patients. Clinically diagnosed case of tuberculosis. Patients with other comorbidities Patients taking medications for other comorbidities Pregnant females 6. Patients not willing to give consent

Design outcomes

Primary

MeasureTime frame
primary outcome is whether the patient is recovered which is evaluated by culture negativityTimepoint: Outcome will be measured at baseline and at 6months—

Secondary

MeasureTime frame
patient achieving cure or having treatment failureTimepoint: after 6 months of treatment—

Countries

India

Contacts

Public ContactDr Gaurav M Rangari

AIIMS,Mangalagiri

gaurav83@aiimsmangalagiri.edu.in6301061687

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026